These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26202258)

  • 1. PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina.
    D'Amico AG; Maugeri G; Reitano R; Bucolo C; Saccone S; Drago F; D'Agata V
    J Mol Neurosci; 2015 Dec; 57(4):501-9. PubMed ID: 26202258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.
    Giunta S; Castorina A; Bucolo C; Magro G; Drago F; D'Agata V
    Peptides; 2012 Sep; 37(1):32-9. PubMed ID: 22721946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nap Interferes with Hypoxia-Inducible Factors and VEGF Expression in Retina of Diabetic Rats.
    D'Amico AG; Maugeri G; Bucolo C; Saccone S; Federico C; Cavallaro S; D'Agata V
    J Mol Neurosci; 2017 Feb; 61(2):256-266. PubMed ID: 27909871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of IL-1β and VEGF expression in rat diabetic retinopathy after PACAP administration.
    D'Amico AG; Maugeri G; Rasà DM; Bucolo C; Saccone S; Federico C; Cavallaro S; D'Agata V
    Peptides; 2017 Nov; 97():64-69. PubMed ID: 28964802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
    Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R
    Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PACAP promotes neuron survival in early experimental diabetic retinopathy.
    Szabadfi K; Szabo A; Kiss P; Reglodi D; Setalo G; Kovacs K; Tamas A; Toth G; Gabriel R
    Neurochem Int; 2014 Jan; 64():84-91. PubMed ID: 24262293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP and VIP Inhibit HIF-1α-Mediated VEGF Expression in a Model of Diabetic Macular Edema.
    Maugeri G; D'Amico AG; Saccone S; Federico C; Cavallaro S; D'Agata V
    J Cell Physiol; 2017 May; 232(5):1209-1215. PubMed ID: 27661459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of PACAP-38 on retinal pigmented epithelium in an in vitro and in vivo model of diabetic retinopathy through EGFR-dependent mechanism.
    Maugeri G; D'Amico AG; Bucolo C; D'Agata V
    Peptides; 2019 Sep; 119():170108. PubMed ID: 31247223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats.
    Wright WS; McElhatten RM; Messina JE; Harris NR
    Exp Eye Res; 2010 Mar; 90(3):405-12. PubMed ID: 20005221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of the neuropeptide PACAP in diabetic retinopathy.
    Szabadfi K; Atlasz T; Kiss P; Reglodi D; Szabo A; Kovacs K; Szalontai B; Setalo G; Banki E; Csanaky K; Tamas A; Gabriel R
    Cell Tissue Res; 2012 Apr; 348(1):37-46. PubMed ID: 22350850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.
    Kvarik T; Mammel B; Reglodi D; Kovacs K; Werling D; Bede B; Vaczy A; Fabian E; Toth G; Kiss P; Tamas A; Ertl T; Gyarmati J; Atlasz T
    J Mol Neurosci; 2016 Oct; 60(2):179-85. PubMed ID: 27561927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIF-1α decreases expression of pro-inflammatory IL-6 and TNF-α in diabetic retinopathy.
    Gao X; Li Y; Wang H; Li C; Ding J
    Acta Ophthalmol; 2017 Dec; 95(8):e746-e750. PubMed ID: 27288252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in retinal hypoxia-inducible factor-2α, but not hypoxia, early in the progression of diabetes in the rat.
    Wright WS; McElhatten RM; Harris NR
    Exp Eye Res; 2011 Oct; 93(4):437-41. PubMed ID: 21689648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin Protects Retinal Cells in Diabetic Rats Through Upregulating ZnT8 via Activating ERK Pathway and Inhibiting HIF-1α Expression.
    Xu G; Kang D; Zhang C; Lou H; Sun C; Yang Q; Lu L; Xu GT; Zhang J; Wang F
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8166-78. PubMed ID: 26720469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Mobility Group Box-1 Modulates the Expression of Inflammatory and Angiogenic Signaling Pathways in Diabetic Retina.
    Abu El-Asrar AM; Mohammad G; Nawaz MI; Siddiquei MM
    Curr Eye Res; 2015; 40(11):1141-52. PubMed ID: 25495026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.
    Hossain A; Heron D; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Wang S; Bhattacharjee PS
    Exp Eye Res; 2016 Aug; 149():100-106. PubMed ID: 27344955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
    Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
    Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin exerts a neuroprotective function against glutamate neurotoxicity in experimental diabetic retina.
    Gu L; Xu H; Wang F; Xu G; Sinha D; Wang J; Xu JY; Tian H; Gao F; Li W; Lu L; Zhang J; Xu GT
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):8208-22. PubMed ID: 25335981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation to hypoxia in the diabetic rat kidney.
    Rosenberger C; Khamaisi M; Abassi Z; Shilo V; Weksler-Zangen S; Goldfarb M; Shina A; Zibertrest F; Eckardt KU; Rosen S; Heyman SN
    Kidney Int; 2008 Jan; 73(1):34-42. PubMed ID: 17914354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.
    Zhang Y; Zhang J; Wang Q; Lei X; Chu Q; Xu GT; Ye W
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):278-85. PubMed ID: 20688733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.